Abnormal laboratory results: Anti-Xa assays
نویسندگان
چکیده
منابع مشابه
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays.
INTRODUCTION Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the effects on common coagulation reagents and assays constitute clinically valuable information. OBJECTIVES To investigate the effects of apixaban on commonly used coagulation methods, and to evaluate anti-FXa assays ...
متن کاملAnti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
INTRODUCTION The aim of this study was to examine the prevalence and functional effects of antibodies directed against Factor (F)Xa and other serine proteases (SP) in patients with antiphospholipid syndrome (APS). METHODS Serum from patients with APS (n=59), systemic lupus erythematosus (SLE; n=106), other autoimmune rheumatic disease (ARD; n=63) and 40 healthy controls (HC) were tested for I...
متن کاملAbnormal Results of Annual Laboratory Checkup in Young Adults
The objective of this descriptive study was to review the usefulness and relevance of the present parameters provided in an annual laboratory health checkup program. Three hundred sixtyfour volunteers were randomly selected, composed of 141 males and 223 females age 15 to 81 years old. Samples from all the volunteers were analyzed for CBC, FBG, BUN, Cr, uric acid, Chol, HDLc, Tg, AST, ALT, ALP,...
متن کاملFacts and artefacts of coagulation assays for factor Xa inhibitors.
Direct factor Xa inhibitors are among the compounds at the forefront of clinical development for the prevention and treatment of thromboembolic disorders; of these, rivaroxaban, apixaban and edoxaban (DU-176b) are in the most advanced stages of development. Rivaroxaban is approved in several countries for the prevention of venous thromboembolism (VTE) after elective hip or knee arthroplasty, an...
متن کاملClinical Scenarios for Discordant Anti-Xa
Anti-Xa test measures the activity of heparin against the activity of activated coagulation factor X; significant variability of anti-Xa levels in common clinical scenarios has been observed. Objective. To review the most common clinical settings in which anti-Xa results can be bias. Evidence Review. Guidelines and current literature search: we used PubMed, Medline, Embase, and MEDION, from 200...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian Prescriber
سال: 2013
ISSN: 0312-8008,1839-3942
DOI: 10.18773/austprescr.2013.036